Research Article

Linc00312 Single Nucleotide Polymorphism as Biomarker for Chemoradiotherapy Induced Hematotoxicity in Nasopharyngeal Carcinoma Patients

Table 3

Multivariate logistic analysis of candidate SNPs and concurrent chemoradiotherapy induced hematotoxicities in NPC patients.

GenotypesLeukopeniaOR (95% CI)ThrombocytopeniaOR (95% CI)

(%)

(%)
Grade 0
(%)

(%)

rs15734 ()
 GG256 (59.3)37 (50.7)1.00 (reference)240 (59.0)53 (54.1)1.00 (reference)
 GA157 (36.3)28 (38.4)1.155 (0.648-2.058)0.626146 (35.9)39 (39.8)1.295 (0.791-2.122)0.304
 AA18 (4.2)8 (11.0)3.145 (1.123-8.806)0.02920 (4.9)6 (6.1)1.293 (0.473-3.530)0.617
vs. GG1.353 (0.787-2.327)0.2741.295 (0.808-2.075)0.283
 AA vs. 2.986 (1.090-8.178)0.0331.175 (0.439-3.150)0.748
rs12497104 ()
 GG145 (33.6)29 (39.7)1.00 (reference)132 (32.4)42 (42.9)1.00 (reference)
 GA199 (46.1)29 (39.7)0.725 (0.397-1.324)0.296186 (45.7)42 (42.9)0.686 (0.411-1.146)0.150
 AA42 (9.7)9 (12.3)0.836 (0.334-2.097)0.70345 (11.1)6 (6.1)0.325 (0.118-0.895)0.030
vs. GG0.747 (0.422-1.321)0.3160.613 (0.373-1.009)0.054
 AA vs. 0.993 (0.418-2.357)0.9870.399 (0.150-1.060)0.065
rs164966 ()
 AA249 (57.6)37 (50.7)1.00 (reference)235 (57.7)51 (52.0)1.00 (reference)
 GA156 (36.1)28 (38.4)1.088 (0.609-1.941)0.776146 (35.9)38 (38.8)1.229 (0.746-2.025)0.419
 GG23 (5.3)8 (11.0)2.554 (0.941-6.930)0.06624 (5.9)7 (7.1)1.228 (0.483-3.125)0.666
vs. AA1.257 (0.731-2.161)0.4081.229 (0.765-1.974)0.395
 GG vs. 2.293 (0.885-5.944)0.0881.135 (0.456-2.827)0.785